Preparing Europe for future health threats and crises ─ the European Medicines Agency; ensuring safe and effective medicines and medical devices

Affiliations

Editorial

Emer Cooke. Euro Surveill. 2022 Oct.

. 2022 Oct;27(42):2200798.

doi: 10.2807/1560-7917.ES.2022.27.42.2200798.

No abstract available

Keywords: EMA; European Health Union; European Medicines Agency; extended mandate; health crisis; medicine regulation; preparedness.

Conflict of interest statement

Conflict of interest: None declared.

1. European Commission (EC). European Health Union. Brussels: EC. [Accessed: 19 Oct 2022]. Available from: https://ec.europa.eu/info/strategy/priorities-2019-2024/promoting-our-eu...
1. Regulation (EU) 2022/123 of the European Parliament and of the Council of 25 January 2022 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices (Text with EEA relevance). Luxembourg: Official Journal of the European Union. 31 Jan 2022. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0123
1. European Medicines Agency (EMA). Regulation on EMA’s extended mandate becomes applicable. Amsterdam: EMA; 1 Mar 2022. Available from: https://www.ema.europa.eu/en/news/regulation-emas-extended-mandate-becom...
1. European Medicines Agency (EMA). Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG). Amsterdam: EMA; 11 May 2022. Available from: https://www.ema.europa.eu/en/about-us/what-we-do/crisis-preparedness-man...
1. European Medicines Agency (EMA). List of critical medicines for COVID-19 public health emergency (PHE) under Regulation (EU) 2022/123. Available from: https://www.ema.europa.eu/en/documents/other/list-critical-medicines-cov...